Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy and of Ivermectin for the Prevention of Severe Disease in Patients With COVID-19: A Randomized, Controlled, Double-Blind Clinical Study.

NCT04886362 is registered in ClinicalTrials.gov with Ayudas Diagnosticas Sura S.A.S as lead sponsor.

NCT NCT04886362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04886362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy and of Ivermectin for the Prevention of Severe Disease in Patients With COVID-19: A Randomized, Controlled, Double-Blind Clinical Study.
Lead sponsor
Ayudas Diagnosticas Sura S.A.S
Phase
Phase 2/3
Overall status
Unknown status
Start date
July 31, 2021
Completion date
December 31, 2021
Enrollment
966 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 pneumonia